arrow
M

Max Jan

massachusetts general hospital
H指数:22
被引数:5,464

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genomic correlates of clinical CAR T cell activity

临床CAR T细胞活性的基因组相关性

2026-07-240
PRE
Genetic retargeting of E3 ligases to enhance CAR T cell therapy
2024-02-017
PRE
Chemical genetic control of cytokine signaling in CAR-T cells using lenalidomide-controlled membrane-bound degradable IL-7

使用来那度胺控制的膜结合可降解IL-7对car-t细胞中的细胞因子信号进行化学遗传控制

LEUKEMIA
IF13.4
2023-12-201
PRE
Clonal hematopoiesis is associated with protection from Alzheimer's disease

克隆造血与阿尔茨海默病的保护有关

2023-06-1539
OAAI
Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma

与难治性b细胞淋巴瘤car-t治疗反应相关的独特细胞动力学

2022-09-12116
OA
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine

钙网蛋白突变体骨髓增生性肿瘤诱导mhc-i偏斜,这可以通过优化的肽癌症疫苗来克服

2022-06-1512
PRE
Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide
2021-01-06178
OA
MHC-I SKEWING IN MUTANT CALRETICULIN-POSITIVE MYELOPROLIFERATIVE NEOPLASMS IS COUNTERED BY HETEROCLITIC PEPTIDE CANCER VACCINATION
2020-11-090
OAAI
Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantation
2019-07-1956
OA
COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis
2015-04-20272
OAAI